Vanguard FTSE Europe ETF | VGKRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 18.0 | -5.4 | 13.4 | 6.0 | |
+/-Cat | -2.4 | -0.6 | 2.1 | 1.1 | -1.1 | |
+/-B’mrk | -5.0 | 9.1 | 0.0 | 4.3 | 0.3 | |
Category: Europe Stock | ||||||
Category Benchmark: MSCI ACWI Ex USA NR USD |
Key Stats | ||
Closing Price 24/04/2024 | USD 66.01 | |
Day Change | -0.47% | |
Morningstar Category™ | Europe Stock | |
Volume | 1546006 | |
Exchange | NYSE ARCA | |
ISIN | US9220428745 | |
Fund Size (Mil) - | - | |
Share Class Size (Mil) 24/04/2024 | USD 19120.39 | |
Ongoing Charge - | -% | |
*
This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced. |
Morningstar Research |
Investment Objective: Vanguard FTSE Europe ETF | VGK |
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe All Cap Index. The index is a market-capitalization-weighted index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Christine Franquin 26/02/2016 | ||
Scott Geiger 01/07/2022 | ||
Inception Date 04/03/2005 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE Dvlp Europe All Cap(US RIC)NR USD | MSCI ACWI Ex USA NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard FTSE Europe ETF | VGK | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.20 |
ASML Holding NV | Technology | 3.09 |
Nestle SA | Consumer Defensive | 2.29 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 1.80 |
Shell PLC | Energy | 1.74 |
Increase Decrease New since last portfolio | ||
Vanguard FTSE Europe ETF | VGK |